APA (7th ed.) Citation

W, W., WD, J., L, W., JH, S., ZJ, L., ZZ, W., . . . W, L. (2026). Global Co-Occurrence Patterns of Ischemic Heart Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease: Spatial Clusters, Risk Factors, and Quality-of-Care Index. Journal of the American Heart Association, 15(9), e046981. https://doi.org/10.1161/JAHA.125.046981

Chicago Style (17th ed.) Citation

W, Wang, Jiang WD, Wang L, Sun JH, Li ZJ, Wu ZZ, Qin AQ, Qiu S, and Liu W. "Global Co-Occurrence Patterns of Ischemic Heart Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease: Spatial Clusters, Risk Factors, And Quality-of-Care Index." Journal of the American Heart Association 15, no. 9 (2026): e046981. https://doi.org/10.1161/JAHA.125.046981.

MLA (9th ed.) Citation

W, Wang, et al. "Global Co-Occurrence Patterns of Ischemic Heart Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease: Spatial Clusters, Risk Factors, And Quality-of-Care Index." Journal of the American Heart Association, vol. 15, no. 9, 2026, p. e046981, https://doi.org/10.1161/JAHA.125.046981.